Icon

ACETADOTE (nda021539)- (6GM/30ML (200MG/ML))

ACETYLCYSTEINE CUMBERLAND PHARMS
6GM/30ML (200MG/ML)
Yes Yes
2035-Feb-10 Expired
2011-Jan-23 None
None No
ACETADOTE is an antidote for acetaminophen overdose indicated to prevent or lessen hepatic injury after ingestion of a potentially hepatotoxic quantity of acetaminophen in patients with an acute ingestion or from repeated supratherapeutic ingestion (RSI)
10 0 9
Total Other Developers 8
Drugs with Suitability No
6GM/30ML (200MG/ML) ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 6
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ********* **** *** ***** ****** ******* *** *********** ****** **. *** - ***, *** & ***, **** ************* ***** *****, *. *. *****, ******** ****, ******** - ************* ******, ******* - ********** ********, *********, ********* ******, ***** (***) ***
****** ********* **** *** ***** ****** ******* *********** ****** **. *** - ***, *** & ***, **** ************* ***** *****, *. *. *****, ******** ****, ******** - ************* ******, ******* - ********** ********, *********, ********* ******, ***** (***) ***
****** ****** ***** ********* ******* *** (*** *****) *********** **** **** ***** ***., *******, ******** (**) *****, ****** ****** (***) ***
****** ***** ****** ***** ****** ************ ******* *********** ****-***, **** **: *, ** ** **, ***, ** ** **, ****, *****, ***, ************ *******, ********** ******, **********, ********* ******, ***** (***) ***
****** ***** ****** ***** ************ ******* *********** ****** **. ***, *** *** ***, ******* ***** *. *. **. ** *******-*******, ******-****** *********, *********, ******* ******, ***** (***) ***
****** ****** ****** ******** ******* *********** *** *****-** & ***, *-**,**,**, ***** ********** ****, *****, ***, *** ******, ***** (***) ***
****** ***** ****** ***** ****** ********, ***. *********** **** ******* **** ****. **** ******* ***** ***** *** *********** *** **** ********* **** **** ***** *** **** **** *** **, ******, ***** ******** (**) *****, ****** ****** (***) ***
****** ************ ******* ********* ********* ****** ******* *********** **** **.: *-**, ************ ********** ****, **************, *** *****, ****, ************** *****, ********* *****, ********* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.